These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25919891)

  • 21. Impaired Antiatherogenic Functions of High-density Lipoprotein in Patients with Ankylosing Spondylitis.
    Gkolfinopoulou C; Stratikos E; Theofilatos D; Kardassis D; Voulgari PV; Drosos AA; Chroni A
    J Rheumatol; 2015 Sep; 42(9):1652-60. PubMed ID: 26233507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein.
    Witting PK; Song C; Hsu K; Hua S; Parry SN; Aran R; Geczy C; Freedman SB
    Free Radic Biol Med; 2011 Oct; 51(7):1390-8. PubMed ID: 21784147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy.
    Sorrentino SA; Besler C; Rohrer L; Meyer M; Heinrich K; Bahlmann FH; Mueller M; Horváth T; Doerries C; Heinemann M; Flemmer S; Markowski A; Manes C; Bahr MJ; Haller H; von Eckardstein A; Drexler H; Landmesser U
    Circulation; 2010 Jan; 121(1):110-22. PubMed ID: 20026785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.
    Alwaili K; Bailey D; Awan Z; Bailey SD; Ruel I; Hafiane A; Krimbou L; Laboissiere S; Genest J
    Biochim Biophys Acta; 2012 Mar; 1821(3):405-15. PubMed ID: 21840418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of periodontal treatment on lipoproteins levels in plasma in patients with periodontitis.
    Pejcic A; Kesic L; Brkic Z; Pesic Z; Mirkovic D
    South Med J; 2011 Aug; 104(8):547-52. PubMed ID: 21886061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.
    Osto E; Doytcheva P; Corteville C; Bueter M; Dörig C; Stivala S; Buhmann H; Colin S; Rohrer L; Hasballa R; Tailleux A; Wolfrum C; Tona F; Manz J; Vetter D; Spliethoff K; Vanhoutte PM; Landmesser U; Pattou F; Staels B; Matter CM; Lutz TA; Lüscher TF
    Circulation; 2015 Mar; 131(10):871-81. PubMed ID: 25673670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-density lipoproteins (HDL) composition and function in preeclampsia.
    Einbinder Y; Biron-Shental T; Agassi-Zaitler M; Tzadikevitch-Geffen K; Vaya J; Khatib S; Ohana M; Benchetrit S; Zitman-Gal T
    Arch Gynecol Obstet; 2018 Aug; 298(2):405-413. PubMed ID: 29938347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome.
    Gomaraschi M; Ossoli A; Favari E; Adorni MP; Sinagra G; Cattin L; Veglia F; Bernini F; Franceschini G; Calabresi L
    Cardiovasc Res; 2013 Oct; 100(1):36-43. PubMed ID: 23812298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDL levels and oxidizability during myocardial infarction are associated with reduced endothelial-mediated vasodilation and nitric oxide bioavailability.
    Carvalho LS; Panzoldo N; Santos SN; Modolo R; Almeida B; Quinaglia E Silva JC; Nadruz W; de Faria EC; Sposito AC;
    Atherosclerosis; 2014 Dec; 237(2):840-6. PubMed ID: 25463131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
    Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U
    Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects.
    Holven KB; Aukrust P; Retterstøl K; Otterdal K; Bjerkeli V; Ose L; Nenseter MS; Halvorsen B
    J Nutr; 2008 Nov; 138(11):2070-5. PubMed ID: 18936200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
    Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
    Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus.
    Batuca JR; Ames PR; Amaral M; Favas C; Isenberg DA; Delgado Alves J
    Rheumatology (Oxford); 2009 Jan; 48(1):26-31. PubMed ID: 19000993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
    Camont L; Lhomme M; Rached F; Le Goff W; Nègre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2715-23. PubMed ID: 24092747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise training in patients with chronic heart failure promotes restoration of high-density lipoprotein functional properties.
    Adams V; Besler C; Fischer T; Riwanto M; Noack F; Höllriegel R; Oberbach A; Jehmlich N; Völker U; Winzer EB; Lenk K; Hambrecht R; Schuler G; Linke A; Landmesser U; Erbs S
    Circ Res; 2013 Dec; 113(12):1345-55. PubMed ID: 24055733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.
    Tölle M; Huang T; Schuchardt M; Jankowski V; Prüfer N; Jankowski J; Tietge UJ; Zidek W; van der Giet M
    Cardiovasc Res; 2012 Apr; 94(1):154-62. PubMed ID: 22328092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies against HDL Components in Ischaemic Stroke and Coronary Artery Disease.
    Batuca JR; Amaral MC; Favas C; Justino GC; Papoila AL; Ames PRJ; Alves JD
    Thromb Haemost; 2018 Jun; 118(6):1088-1100. PubMed ID: 29723873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
    März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR
    Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.